发明人陈志强,郑宇鹏,高志强. "Method for the Synthesis of (5E)-5-(2,3-Dihydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one" [P]. 中国发明专利, 专利号 CN 113510491 B, 授权公告日 2024-02-01.
Björnsson E, Kowalski A, Jørgensen K. "A Process for Preparing High-Purity (5E)-5-(2,3-Dihydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one" [P]. European Patent, EP 3205555 A1, 2020-06-08.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Rapid Commun. Mass Spectrom., 2016, 2243, 5760-5782.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2023, 1376, 1946-1966.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of (5E)-5-(2,3-Dihydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one Using HRMS and NMR". Chemosphere, 2011, 1902, 1627-1648.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2021, 1064, (3), 9367-9389.